3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Phase 1
1
Status
Unknown
1
Completed
1
Sponsor Class
OTHER
85
INDUSTRY
73
NIH
13
NETWORK
8
OTHER_GOV
2
Study Type
Interventional
2
Sponsor
Cancer Type
Breast
2
Sarcoma
1
Gastrointestinal
1
Conditions
Breast Neoplasms
2
Interventions
Tamoxifen
10
Capecitabine
10
Trastuzumab
9
Docetaxel
9
pyrotinib
7
Exercise
7
Control Groups
7
Vinorelbine
6
Paclitaxel
6
Letrozole
6
Gemcitabine
6
Cyclophosphamide
6
Carboplatin
6
exemestane
5
Indocyanine Green
5
Anastrozole
5
pertuzumab
4
dalpiciclib
4
Injections
4
Fulvestrant
4
Doxorubicin
4
Surgical Procedures, Operative
3
Standard of Care
3
Radiotherapy
3
Radiation
3
Mammography
3
Epirubicin
3
Drug Therapy
3
Cisplatin
3
Bevacizumab
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
OTHER_GOV
×
Lapatinib
×
Breast
×
Clear all
NCT01730677
2014-03-12
LV
National Cancer Center, Korea
Phase 2
Unknown
150 enrolled
NCT01133912
2012-01-04
PGT
National Cancer Center, Korea
Phase 1
Completed
13 enrolled